These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19870119)

  • 1. ACTIVE IMMUNIZATION OF MICE WITH THE POLYSACCHARIDES OF PNEUMOCOCCI TYPES I, II AND III.
    Zozaya J; Clark J
    J Exp Med; 1933 Jan; 57(1):21-40. PubMed ID: 19870119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STEPWISE INTRATYPE TRANSFORMATION OF PNEUMOCOCCUS FROM R TO S BY WAY OF A VARIANT INTERMEDIATE IN CAPSULAR POLYSACCHARIDE PRODUCTION.
    Macleod CM; Krauss MR
    J Exp Med; 1947 Nov; 86(6):439-52. PubMed ID: 19871689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPECIFIC ANTIBODY RESPONSE OF HUMAN SUBJECTS TO INTRACUTANEOUS INJECTION OF PNEUMOCOCCUS PRODUCTS.
    Finland M; Sutliff WD
    J Exp Med; 1932 May; 55(6):853-65. PubMed ID: 19870036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : II. RESISTANCE TO INFECTION.
    Julianelle LA
    J Exp Med; 1930 Feb; 51(3):449-62. PubMed ID: 19869703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE EFFECT OF THE BACTERIOLYTIC ENZYME OF PNEUMOCOCCUS UPON THE ANTIGENICITY OF ENCAPSULATED PNEUMOCOCCI.
    Dubos RJ
    J Exp Med; 1937 Jun; 66(1):113-23. PubMed ID: 19870645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DECOMPOSITION OF THE CAPSULAR POLYSACCHARIDE OF PNEUMOCOCCUS TYPE III BY A BACTERIAL ENZYME.
    Dubos R; Avery OT
    J Exp Med; 1931 Jun; 54(1):51-71. PubMed ID: 19869902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : V. THE IMMUNOLOGICAL SPECIFITY OF AN ANTIGEN PREPARED BY COMBINING THE CAPSULAR POLYSACCHARIDE OF TYPE III PNEUMOCOCCUS WITH FOREIGN PROTEIN.
    Avery OT; Goebel WF
    J Exp Med; 1931 Jul; 54(3):437-47. PubMed ID: 19869930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive effects of certain transforming agents from some variants of pneumococcus.
    TAYLOR HE
    J Exp Med; 1949 Apr; 89(4):399-424. PubMed ID: 18113913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High-molecular antigenic complex of the pneumococcus: its properties].
    Rodionychev EA; Krasnoproshina LI; Padiukov LN; Tsvetkova NV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Mar; (3):23-8. PubMed ID: 3993288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus.
    Winkelstein JA; Bocchini JA; Schiffman G
    J Immunol; 1976 Feb; 116(2):367-70. PubMed ID: 2634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RESULTS OF PROPHYLACTIC INOCULATION AGAINST PNEUMOCOCCUS IN 12,519 MEN.
    Cecil RL; Austin JH
    J Exp Med; 1918 Jul; 28(1):19-41. PubMed ID: 19868242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANTIBODY FORMATION IN MEN FOLLOWING INJECTION OF FOUR TYPE-SPECIFIC POLYSACCHARIDES OF PNEUMOCOCCUS.
    Heidelberger M; Macleod CM; Hodges RG; Bernhard WG; di Lapi MM
    J Exp Med; 1947 Feb; 85(3):227-30. PubMed ID: 19871610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sedimentation and viscosity studies on the capsular and somatic polysaccharides of pneumococcus Type III.
    KOENIG VL; PERRINGS JD
    J Biophys Biochem Cytol; 1955 Mar; 1(2):93-8. PubMed ID: 14381431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A STUDY OF PNEUMOCOCCI REACTING WITH ANTIPNEUMOCOCCUS SERA OF TYPES I, II, AND III, WITH AN OBSERVATION OF A MUTATION OF ONE OF THE STRAINS.
    Clough MC
    J Exp Med; 1919 Aug; 30(2):123-46. PubMed ID: 19868349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CARBOHYDRATES ADSORBED ON COLLOIDS AS ANTIGENS.
    Zozaya J
    J Exp Med; 1932 Feb; 55(3):325-51. PubMed ID: 19869994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STUDIES ON PNEUMOCOCCUS IMMUNITY : II. ACTIVE IMMUNIZATION OF MONKEYS AGAINST PNEUMOCOCCUS TYPES II, III, AND IV PNEUMONIA WITH THE HOMOLOGOUS PNEUMOCOCCUS VACCINE.
    Cecil RL; Steffen GI
    J Exp Med; 1923 Jul; 38(2):149-61. PubMed ID: 19868780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : III. INCREASED RESISTANCE TO TYPE III INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R AND S FORMS OF PNEUMOCOCCUS.
    Tillett WS
    J Exp Med; 1927 Jul; 46(2):343-56. PubMed ID: 19869342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE ANTIPNEUMOCOCCUS PROPERTIES OF NORMAL SWINE SERUM.
    Kelley WH
    J Exp Med; 1932 May; 55(6):877-88. PubMed ID: 19870038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : II. THE INFECTIVITY OF TYPE III PNEUMOCOCCUS FOR RABBITS.
    Tillett WS
    J Exp Med; 1927 May; 45(6):1093-106. PubMed ID: 19869308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CUTANEOUS REACTIONS IN RABBITS TO THE TYPE-SPECIFIC CAPSULAR POLYSACCHARIDES OF PNEUMOCOCCUS.
    Francis T; Tillett WS
    J Exp Med; 1931 Sep; 54(4):587-96. PubMed ID: 19869942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.